OBJECTIVE: To assess the degree of agreement between standard error of measurement (SEM) and minimally important difference (MID) criteria to evaluate the magnitude of the change caused by a medical intervention. STUDY DESIGN AND SETTING: Data were obtained from a cohort of 603 patients with neuropathic pain undergoing analgesic treatment with gabapentin who completed four health scales: Medical Outcomes Study Sleep Scale, Sheehan Disability Scale, Covi Anxiety Scale, and Raskin Depression scale. After calculating MID and SEM values for all scales, patients were classified into three categories: improvement, no change, and worsening. Agreement between the two criteria was assessed using Cohen's kappa index of agreement and Kendall's tau-b linear correlation coefficient. RESULTS: The 1 SEM criterion showed the highest agreement (kappa=0.68-1.00) and correlation (tau-b=0.75-1.00) with the MID criterion. Sensitivity analysis performed in gabapentin responders and nonresponders confirmed the results of the main analysis. CONCLUSION: The 1 SEM criterion is a valid alternative to the MID criterion to evaluate the magnitude of the change produced in patient-reported health outcomes measures.
OBJECTIVE: To assess the degree of agreement between standard error of measurement (SEM) and minimally important difference (MID) criteria to evaluate the magnitude of the change caused by a medical intervention. STUDY DESIGN AND SETTING: Data were obtained from a cohort of 603 patients with neuropathic pain undergoing analgesic treatment with gabapentin who completed four health scales: Medical Outcomes Study Sleep Scale, Sheehan Disability Scale, Covi Anxiety Scale, and Raskin Depression scale. After calculating MID and SEM values for all scales, patients were classified into three categories: improvement, no change, and worsening. Agreement between the two criteria was assessed using Cohen's kappa index of agreement and Kendall's tau-b linear correlation coefficient. RESULTS: The 1 SEM criterion showed the highest agreement (kappa=0.68-1.00) and correlation (tau-b=0.75-1.00) with the MID criterion. Sensitivity analysis performed in gabapentin responders and nonresponders confirmed the results of the main analysis. CONCLUSION: The 1 SEM criterion is a valid alternative to the MID criterion to evaluate the magnitude of the change produced in patient-reported health outcomes measures.
Authors: John Eric Jelovsek; Zhen Chen; Alayne D Markland; Linda Brubaker; Keisha Y Dyer; Susie Meikle; David D Rahn; Nazeema Y Siddiqui; Ashok Tuteja; Matthew D Barber Journal: Female Pelvic Med Reconstr Surg Date: 2014 Nov-Dec Impact factor: 2.091
Authors: Matthew D Barber; Cathie Spino; Nancy K Janz; Linda Brubaker; Ingrid Nygaard; Charles W Nager; Thomas L Wheeler Journal: Am J Obstet Gynecol Date: 2009-05 Impact factor: 8.661
Authors: Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Mario Alvarez-Sanchez; Tomoko Arakaki; Alberto Bergareche-Yarza; Anabel Chade; Nelida Garretto; Oscar Gershanik; Monica M Kurtis; Juan Carlos Martinez-Castrillo; Amelia Mendoza-Rodriguez; Henry P Moore; Mayela Rodriguez-Violante; Carlos Singer; Barbara C Tilley; Jing Huang; Glenn T Stebbins; Christopher G Goetz Journal: J Neurol Date: 2012-08-05 Impact factor: 4.849
Authors: Amanda Purcell; Jennifer Fleming; Sally Bennett; Bryan Burmeister; Terry Haines Journal: Support Care Cancer Date: 2009-05-26 Impact factor: 3.603